In September 2023, several ongoing mini-HTA assessments for e-health, gastrointestinal, IVD, neurology and neurosurgery, peripheral vascular, pulmonary and airways, and some other fields are evaluated as a part of a framework for the managed introduction of innovations "New Methods" in Norway.

The EUnetHTA 21 Consortium will cease operating on 16 September 2023. The HTA Regulation Secretariat at the European Commission will be the contact point for matters related to HTA collaboration under the HTAR.

Between late May and early September 2023, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, 49 health apps are currently available in the DiGA Directory, and six health apps were delisted from the Directory.

In September 2023, the Galician Agency for Health Technology Assessment (AVALIA-T) is working on several HTAs, including the evaluations in the cardiovascular, e-health, endoscopy, extracorporeal treatment, ICU/OR, nephrology and urology, IVD, obstetrics and gynecology, orthopedics, peripheral vascular, pulmonary and airways, surgical procedures, and some other fields.

On August 24, 2023, the National Association of Statutory Health Insurance Physicians (KBV) informed that new services for serological diagnostics of Toxoplasma infection will be included in the German Uniform Evaluation Standard (EBM) catalog since October 1, 2023.

On August 30, 2023, the National Board of Health and Welfare introduced national screening for spinal muscular atrophy (SMA) in newborns. The screening test will identify children with homozygous deletion in the SMN1 gene and 1–3 copies of the SMN2 gene. As a result, those affected by the most severe forms of SMA can receive treatment before the onset of symptoms.

The National Genomic Test Directory lists genomic tests commissioned by NHS England via Genomic Laboratory Hubs. It is updated annually. The applications submitted before April 1, 2024, to add new tests or change existing ones will be considered for implementation on April 1, 2025.

In August 2023, Danish Regions supported establishing a new Board for Health Apps proposed by the Ministry of the Interior and Health. It is expected that recommendations from the Board will significantly impact the adoption of health apps.

On July 1, 2023, the updated Framework Contract that defines Romania's social health insurance benefit package entered into force. The Framework Contract defines the SHI benefits package, the conditions for providing services and payments. The updated Framework Contract will be valid for the years 2023-2024.

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in August 2023. Eight recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular, peripheral vascular and neurovascular devices, as well as medical aids.

In August 2023, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedure Guidance (aortic valve reconstruction with glutaraldehyde-treated autologous pericardium for aortic valve disease) and one new Diagnostic Guidance (quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care). Also, five clinical guidelines were updated.

In August 2023, the Evaluation and Planning Service of the Canary Islands Health Service (SESCS) is working on several HTAs, including evaluations in the cardiovascular, endocrine, neurology and neurosurgery, orthopedics, surgical procedures, and some other fields.